Transforming growth factor-β in the brain regulates fat metabolism during endurance exercise

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 6, 2006, Pages

  Ishikawa, Toma ^a   Mizunoya, Wataru ^a   Shibakusa, Tetsuro ^a   Inoue, Kazuo ^a   Fushiki, Tohru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Activin receptor like kinase 5; Central nervous system; Corticotropin releasing factor; Energy metabolism; Respiratory exchange ratio

Indexed keywords

ASTRESSIN; CORTICOTROPIN RELEASING FACTOR; KETONE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ANIMAL EXPERIMENT; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; ENERGY METABOLISM; EXERCISE; GAS ANALYSIS; LIPID METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TREADMILL EXERCISE;

ANIMALS; BLOOD GAS ANALYSIS; BLOOD GLUCOSE; BRAIN CHEMISTRY; CORTICOTROPIN-RELEASING HORMONE; ENERGY METABOLISM; EXERTION; LIPID METABOLISM; MALE; OXYGEN CONSUMPTION; PHYSICAL ENDURANCE; RATS; RATS, SPRAGUE-DAWLEY; REST; RUNNING; TRANSFORMING GROWTH FACTOR BETA;

EID: 33845387828     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00039.2006     Document Type: Article

References (40)

1. Arai M, Yamazaki H, Inoue K, and Fushiki T. Effects of intracranial injection of transforming growth factor-beta relevant to central fatigue on the waking electroencephalogram of rats: comparison with effects of exercise. Prog Neuropsychopharmacol Biol Psychiatry 26: 307-312, 2002.
2. Bovetto S, Rouillard C, and Richard D. Role of CRH in the effects of 5-HT-receptor agonists on food intake and metabolic rate. Am J Physiol Regul Integr Comp Physiol 271: R1231-R1238, 1996.
3. Brown MR, Fisher LA, Rivier J, Spiess J, Rivier C, and Vale W. Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption. Life Sci 30: 207-210, 1982.
4. Callahan JF, Burgess JL, Fornwald JA, Gaster LM, Harling JD, Harrington FP, Heer J, Kwon C, Lehr R, Mathur A, Olson BA, Weinstock J, and Laping NJ. Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5). J Med Chem 45: 999-1001, 2002.
5. Cleroux J, Van Nguyen P, Taylor AW, and Leenen FH. Effects of beta 1- vs. beta 1 + beta 2-blockade on exercise endurance and muscle metabolism in humans. J Appl Physiol 66: 548-554, 1989.
6. Clutter WE, Bier DM, Shah SD, and Cryer PE. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 66: 94-101, 1980.
7. Coppari R, Ichinose M, Lee CE, Pullen AE, Kenny CD, McGovern RA, Tang V, Liu SM, Ludwig T, Chua SC Jr, Lowell BB, and Elmquist JK. The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab 1: 63-72, 2005.
8. Couturier K, Belanger P, Latour MG, and Lavoie JM. Evidence that a decrease in liver glycogen content stimulates FFA mobilization during exercise. Can J Appl Physiol 25: 141-152, 2000.
9. Coyle EF, Jeukendrup AE, Wagenmakers AJ, and Saris WH. Fatty acid oxidation is directly regulated by carbohydrate metabolism during exercise. Am J Physiol Endocrinol Metab 273: E268-E275, 1997.
10. De Fanti BA and Martinez JA. Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats. Brain Res 930: 37-41, 2002.
11. Farrell PA, Garthwaite TL, and Gustafson AB. Plasma adrenocorticotropin and cortisol responses to submaximal and exhaustive exercise. J Appl Physiol 55: 1441-1444, 1983.
12. Gelling RW, Morton GJ, Morrison CD, Niswender KD, Myers MG Jr, Rhodes CJ, and Schwartz MW. Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes. Cell Metab 3: 67-73, 2006.
13. Gulyas J, Rivier C, Perrin M, Koerber SC, Sutton S, Corrigan A, Lahrichi SL, Craig AG, Vale W, and Rivier J. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc Natl Acad Sci USA 92: 10575-10579, 1995.
14. Hargreaves M, McConell G, and Proietto J. Influence of muscle glycogen on glycogenolysis and glucose uptake during exercise in humans. J Appl Physiol 78: 288-292, 1995.
15. Hickson RC, Rennie MJ, Conlee RK, Winder WW, and Holloszy JO. Effects of increased plasma fatty acids on glycogen utilization and endurance. J Appl Physiol 43: 829-833, 1977.
16. Hjelmeland MD, Hjelmeland AB, Sathornsumetee S, Reese ED, Herbstreith MH, Laping NJ, Friedman HS, Bigner DD, Wang XF, and Rich JN. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol Cancer Ther 3: 737-745, 2004.
17. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, and Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74, 2002.
18. Inoue K, Yamazaki H, Manabe Y, Fukuda C, Hanai K, and Fushiki T. Transforming growth factor-beta activated during exercise in brain depresses spontaneous motor activity of animals. Relevance to central fatigue. Brain Res 846: 145-153, 1999.
19. Ishihara K, Oyaizu S, Onuki K, Lim K, and Fushiki T. Chronic (-)-hydroxycitrate administration spares carbohydrate utilization and promotes lipid oxidation during exercise in mice. J Nutr 130: 2990-2995, 2000.
20. Kawaguchi M, Scott KA, Moran TH, and Bi S. Dorsomedial hypothalamic corticotropin-releasing factor mediation of exercise-induced anorexia. Am J Physiol Regul Integr Comp Physiol 288: R1800-R1805, 2005.
21. Kim KM, Kawada T, Ishihara K, Inoue K, and Fushiki T. Swimming capacity of mice is increased by oral administration of a nonpungent capsaicin analog, stearoyl vanillylamide. J Nutr 128: 1978-1983, 1998.
22. Klein S, Coyle EF, and Wolfe RR. Fat metabolism during low-intensity exercise in endurance-trained and untrained men. Am J Physiol Endocrinol Metab 267: E934-E940, 1994.
23. Lam TK, Gutierrez-Juarez R, Pocai A, and Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 309: 943-947, 2005.
24. Langfort J, Ploug T, Ihlemann J, Holm C, and Galbo H. Stimulation of hormone-sensitive lipase activity by contractions in rat skeletal muscle. Biochem J 351: 207-214, 2000.
25. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, and Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343, 2002.
26. Pequignot JM, Peyrin L, and Peres G. Catecholamine-fuel interrelationships during exercise in fasting men. J Appl Physiol 48: 109-113, 1980.
27. Pocai A, Obici S, Schwartz GJ, and Rossetti L. A brain-liver circuit regulates glucose homeostasis. Cell Metab 1: 53-61, 2005.
28. Randle PJ, Garland PB, Hales CN, and Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
29. Randle PJ, Newsholme EA, and Garland PB. Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J 93: 652-665, 1964.
30. Rifkin DB. Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J Biol Chem 280: 7409-7412, 2005.
31. Schwartz MW and Porte D Jr. Diabetes, obesity, and the brain. Science 307: 375-379, 2005.
32. Spriet LL and Watt MJ. Regulatory mechanisms in the interaction between carbohydrate and lipid oxidation during exercise. Acta Physiol Scand 178: 443-452, 2003.
33. Timofeeva E, Huang Q, and Richard D. Effects of treadmill running on brain activation and the corticotropin-releasing hormone system. Neuroendocrinology 77: 388-405, 2003.
34. Wahrenberg H, Engfeldt P, Bolinder J, and Arner P. Acute adaptation in adrenergic control of lipolysis during physical exercise in humans. Am J Physiol Endocrinol Metab 253: E383-E390, 1987.
35. Weltan SM, Bosch AN, Dennis SC, and Noakes TD. Influence of muscle glycogen content on metabolic regulation. Am J Physiol Endocrinol Metab 274: E72-E82, 1998.
36. Winder WW, Arogyasami J, Elayan IM, and Cartmill D. Time course of exercise-induced decline in malonyl-CoA in different muscle types. Am J Physiol Endocrinol Metab 259: E266-E271, 1990.
37. 2 max and cardiac hypertrophy. Am J Physiol Heart Circ Physiol 280: H1301-H1310, 2001.
38. Wojtaszewski JF, MacDonald C, Nielsen JN, Hellsten Y, Hardie DG, Kemp BE, Kiens B, and Richter EA. Regulation of 5′-AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813-E822, 2003.
39. Yamazaki H, Arai M, Matsumura S, Inoue K, and Fushiki T. Intracranial administration of transforming growth factor-beta3 increases fat oxidation in rats. Am J Physiol Endocrinol Metab 283: E536-E544, 2002.
40. Yue J and Mulder KM. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther 91: 1-34, 2001.